Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

448 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study.
Christ SM, Alongi F, Ricardi U, Scorsetti M, Livi L, Balermpas P, Lievens Y, Braam P, Jereczek-Fossa BA, Stellamans K, Ratosa I, Widder J, Peulen H, Dirix P, Bral S, Ramella S, Hemmatazad H, Khanfir K, Geets X, Jeene P, Zilli T, Fournier B, Ivaldi GB, Clementel E, Fortpied C, Oppong FB, Ost P, Guckenberger M. Christ SM, et al. Among authors: livi l. Radiother Oncol. 2024 Jun;195:110235. doi: 10.1016/j.radonc.2024.110235. Epub 2024 Mar 19. Radiother Oncol. 2024. PMID: 38508239 Free article.
Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
Livi L, Meattini I, Franceschini D, Saieva C, Meacci F, Marrazzo L, Gerlain E, Desideri I, Scotti V, Nori J, Sanchez LJ, Orzalesi L, Bonomo P, Greto D, Bianchi S, Biti G. Livi L, et al. Radiother Oncol. 2013 Aug;108(2):273-8. doi: 10.1016/j.radonc.2013.02.009. Epub 2013 Mar 13. Radiother Oncol. 2013. PMID: 23490271
The "PROCAINA (PROstate CAncer INdication Attitudes) Project" (Part II)--a survey among Italian radiation oncologists on radical radiotherapy in prostate cancer.
De Bari B, Alongi F, Franco P, Ciammella P, Chekrine T, Livi L, Jereczek-Fossa BA, Filippi AR; AIRO Young and AIRO Prostate cancer Working Group. De Bari B, et al. Among authors: livi l. Radiol Med. 2013 Oct;118(7):1220-39. doi: 10.1007/s11547-013-0925-z. Epub 2013 May 27. Radiol Med. 2013. PMID: 23716281
In Regard to Boero et al.
Alongi F, Meattini I, Mazzola R, Giaj Levra N, Fiorentino A, Livi L. Alongi F, et al. Among authors: livi l. Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):855-6. doi: 10.1016/j.ijrobp.2016.01.024. Int J Radiat Oncol Biol Phys. 2016. PMID: 27131087 No abstract available.
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study).
Meattini I, Pasinetti N, Meduri B, De Rose F, De Santis MC, Franco P, Lancellotta V, Rossi F, Saieva C, Desideri I, Delli Paoli C, D'Angelo E, Triggiani L, Bastiani P, Alongi F, Lozza L, Aristei C, Ricardi U, Scorsetti M, Livi L; Clinical Oncology Breast Cancer Group (COBCG) Investigators. Meattini I, et al. Among authors: livi l. Radiother Oncol. 2019 Feb;131:208-214. doi: 10.1016/j.radonc.2018.07.015. Epub 2018 Jul 31. Radiother Oncol. 2019. PMID: 30075864 Free article.
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).
Navarria P, Minniti G, Clerici E, Tomatis S, Pinzi V, Ciammella P, Galaverni M, Amelio D, Scartoni D, Scoccianti S, Krengli M, Masini L, Draghini L, Maranzano E, Borzillo V, Muto P, Ferrarese F, Fariselli L, Livi L, Pasqualetti F, Fiorentino A, Alongi F, di Monale MB, Magrini S, Scorsetti M. Navarria P, et al. Among authors: livi l. J Neurooncol. 2019 Mar;142(1):59-67. doi: 10.1007/s11060-018-03059-x. Epub 2018 Dec 4. J Neurooncol. 2019. PMID: 30515706
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy.
Arcangeli S, Jereczek-Fossa BA, Alongi F, Aristei C, Becherini C, Belgioia L, Buglione M, Caravatta L, D'Angelillo RM, Filippi AR, Fiore M, Genovesi D, Greco C, Livi L, Magrini SM, Marvaso G, Mazzola R, Meattini I, Merlotti A, Palumbo I, Pergolizzi S, Ramella S, Ricardi U, Russi E, Trovò M, Sindoni A, Valentini V, Corvò R. Arcangeli S, et al. Among authors: livi l. Crit Rev Oncol Hematol. 2019 Feb;134:87-103. doi: 10.1016/j.critrevonc.2018.11.005. Epub 2018 Dec 1. Crit Rev Oncol Hematol. 2019. PMID: 30658886 Review.
448 results